The immunological perspective of major depressive disorder: unveiling the interactions between central and peripheral immune mechanisms
Top Cited Papers
Open Access
- 19 January 2025
- journal article
- review article
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 22 (1) , 1-19
Abstract
Major depressive disorder is a prevalent mental disorder, yet its pathogenesis remains poorly understood. Accumulating evidence implicates dysregulated immune mechanisms as key contributors to depressive disorders. This review elucidates the complex interplay between peripheral and central immune components underlying depressive disorder pathology. Peripherally, systemic inflammation, gut immune dysregulation, and immune dysfunction in organs including gut, liver, spleen and adipose tissue influence brain function through neural and molecular pathways. Within the central nervous system, aberrant microglial and astrocytes activation, cytokine imbalances, and compromised blood-brain barrier integrity propagate neuroinflammation, disrupting neurotransmission, impairing neuroplasticity, and promoting neuronal injury. The crosstalk between peripheral and central immunity creates a vicious cycle exacerbating depressive neuropathology. Unraveling these multifaceted immune-mediated mechanisms provides insights into major depressive disorder’s pathogenic basis and potential biomarkers and targets. Modulating both peripheral and central immune responses represent a promising multidimensional therapeutic strategy.Keywords
Funding Information
- National Natural Science Foundation of China (82200616, 82204655)
- Guangdong Medical Research Foundation (A2022047)
- Traditional Chinese Medicine Bureau of Guangdong Province (20231082)
This publication has 280 references indexed in Scilit:
- Acute systemic inflammation exacerbates neuroinflammation in Alzheimer's disease: IL‐1β drives amplified responses in primed astrocytes and neuronal network dysfunctionAlzheimer's & Dementia, 2021
- Prescription Opioid Use and Risk for Major Depressive Disorder and Anxiety and Stress-Related DisordersJAMA Psychiatry, 2021
- Dissecting the Association Between Inflammation, Metabolic Dysregulation, and Specific Depressive SymptomsJAMA Psychiatry, 2021
- Psychosocial Interventions and Immune System FunctionJAMA Psychiatry, 2020
- Efficacy of Adjunctive Infliximab vs Placebo in the Treatment of Adults With Bipolar I/II DepressionJAMA Psychiatry, 2019
- Regionally selective knockdown of astroglial glutamate transporters in infralimbic cortex induces a depressive phenotype in miceGlia, 2019
- Altered serum levels of TNF-α, IL-6, and IL-18 in depressive disorder patientsHuman Psychopharmacology: Clinical and Experimental, 2017
- The microglial ATP‐gated ion channel P2X7 as a CNS drug targetGlia, 2016
- KETAMINE'S MECHANISM OF ACTION: A PATH TO RAPID‐ACTING ANTIDEPRESSANTSDepression and Anxiety, 2016
- Neuroprotective and neurorestorative properties of GDNFAnnals of Neurology, 1998